Cargando…
The Soluble Folate Receptor in Autism Spectrum Disorder: Relation to Autism Severity and Leucovorin Treatment
Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental disorder with life-long consequences that affects up to 1 in 44 children. Treatment with leucovorin (folinic acid), a reduced form of folate, has been shown to improve symptoms in those with ASD and folate pathway abnormalities in...
Autores principales: | Frye, Richard E., Lane, Alison, Worner, Ashley, Werner, Brianna A., McCarty, Patrick J., Scheck, Adrienne C., Collins, Heidi L., Adelman, Steven J., Quadros, Edward V., Rossignol, Daniel A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786140/ https://www.ncbi.nlm.nih.gov/pubmed/36556254 http://dx.doi.org/10.3390/jpm12122033 |
Ejemplares similares
-
Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021) -
Cerebral folate receptor autoantibodies in autism spectrum disorder
por: Frye, R E, et al.
Publicado: (2013) -
Treatment of Folate Metabolism Abnormalities in Autism Spectrum Disorder
por: Frye, Richard E., et al.
Publicado: (2020) -
Correction: Rossignol, D.A.; Frye, R.E. Cerebral Folate Deficiency, Folate Receptor Alpha Autoantibodies and Leucovorin (Folinic Acid) Treatment in Autism Spectrum Disorders: A Systematic Review and Meta-Analysis. J. Pers. Med. 2021, 11, 1141
por: Rossignol, Daniel A., et al.
Publicado: (2022) -
Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
por: Frye, Richard E., et al.
Publicado: (2016)